MGRXNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31

MANGOCEUTICALS, INC.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026

$0.28−0.01 (-3.38%)

Close on Oct 19, 2026

Market cap: $4.80M
P/E (TTM): –
Dividend yield: –

MANGOCEUTICALS, INC. balance sheet

Annual Quarterly

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Cash & Equivalents	1.49	0.06	0.74	0.68	–
Cash & Short-Term Investments	1.49	0.06	0.74	0.68	–
Inventory	–	–	0.02	–	–
Total Current Assets	1.55	0.08	0.84	0.69	–
Property, Plant & Equipment	0.00	0.00	0.10	0.12	–
Accumulated Depreciation	0.00	0.00	-0.03	0.00	–
Machinery & Equipment	–	0.12	0.12	–	–
Operating Lease Right-of-Use Assets	0.31	0.06	0.12	0.17	–
Intangible Assets	14	15	–	–	–
Total Assets	16	15	1.05	1.00	–
Accounts Payable	0.42	0.84	0.14	0.03	–
Current Portion of Leases	0.31	0.06	0.06	0.06	–
Other Current Liabilities	–	0.37	–	–	–
Total Current Liabilities	0.89	1.43	0.21	0.26	–
Long-Term Leases	–	–	0.06	0.13	–
Operating Lease Liabilities	0.31	0.06	0.13	0.19	–
Total Liabilities	0.89	1.43	0.28	0.39	–
Common Stock	0.00	0.00	0.00	0.00	–
Additional Paid-In Capital	56	35	12	2.63	–
Retained Earnings	-41	-20	-11	-2.02	–
Comprehensive Income & Other	0.00	-0.01	–	–	–
Shareholders' Equity	15	14	0.77	0.61	-0.02
Noncontrolling Interest	0.00	0.00	–	–	–
Total Equity	15	14	0.77	0.61	-0.02
Total Liabilities & Equity	16	15	1.05	1.00	–
Shares Outstanding(shares)	16	3.25	1.43	0.89	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 54.4%
Operating margin: -3829.0%
Net margin: -4791.3%
Return on equity, FY2025: -141.6%

Financial strength

Current ratio: 0.18
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 16.4%

Valuation

P/E ratio: –
Price to sales: 15.21
Price to book: 0.38
Dividend yield: –